Finance

Beta
Lists
4591:TYO
Ribomic Inc
¥63.00
+1.61%
(+1.00) 1D
Jun 12, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4591...
Open
¥62
High
¥64
Low
¥61
Mkt. cap
3.53B
Avg. vol.
583.69K
Volume
546.60K
52-wk high
¥141
52-wk low
¥60
EPS
-¥23
Shares outstanding
14.39M
No. of employees
25
Open
¥62
High
¥64
Low
¥61
Mkt. cap
3.53B
Avg. vol.
583.69K
Volume
546.60K
52-wk high
¥141
52-wk low
¥60
EPS
-¥23
Shares outstanding
14.39M
No. of employees
25
News stories
From sources across the web
About Ribomic Inc
CEO-
Employees25
FoundedAug 1, 2003
Headquarters-
SectorBiotechnology
Websiteribomic.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
750.00K
2.25M
Cost of goods sold
-
334.00M
-
-
Cost of revenue
-
334.00M
-
-
Research and development expenses
166.75M
-136.00M
157.52M
311.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102.36M
101.00M
93.20M
109.08M
Operating expense
269.11M
-35.00M
250.72M
421.06M
Total operating expenses
269.11M
299.00M
250.72M
421.06M
Operating income
-269.11M
-299.00M
-249.96M
-418.81M
Other non operating income
10.82M
10.00M
-1.22M
35.59M
EBT including unusual items
-256.78M
-287.00M
-248.82M
-381.62M
EBT excluding unusual items
-256.78M
-287.00M
-248.82M
-376.62M
Income tax expense
302.50K
-
302.00K
93.00K
Effective tax rate
-0.12%
-
-0.12%
-0.02%
Other operating expenses
-
-
-
-
Net income
-257.08M
-287.00M
-249.12M
-381.71M
Net profit margin
-
-
-33,216.27%
-16,964.84%
Earnings per share
-
-
-
-
Interest and investment income
1.65M
2.00M
2.22M
6.48M
Interest expense
-
-
-
-
Net interest expenses
1.65M
2.00M
2.22M
6.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
-268.19M
-298.50M
-249.04M
-418.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer